Drug · DIN 02562510
ENZEEVU
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 9, 2026; first marketed February 9, 2026.
- Drug Identification Number (DIN)
- 02562510
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Aflibercept S01LA05
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFLIBERCEPT | 2 MG | 0.05 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 30, 2025: NOC 36288New Drug Submission (NDS)
Other DINs named ENZEEVU
- DIN 02562529 · Approved